Doctor's Dilemma: Confronting Racist Patients
White coats and hospital walls don't protect physicians of color from racist patients. About 70% of Asian and black doctors deal with biased comments.LEARN MORE
Tinnitus affects millions of Americans, and many are forced to treat debilitating cases with invasive surgery — but that could change.
For the roughly 2 million Americans with tinnitus, a condition that causes constant ringing in the ear, the sound can be so intense it can make it hard to work or do basic tasks. Invasive surgery can treat it, but a new study shows an effective, non-invasive way might fix the problem.
It's thought tinnitus happens when damaged nerve cells send the wrong information to the brain — like the brain interpreting touch signals as sound. Knowing this, the researchers wanted to see if a device that uses sound while stimulating the skin could help stop those misfires.
To find out, they conducted an experiment where tinnitus sufferers were given two different versions of a device: One played sounds and shocked participants, and another just played sounds. Participants noted how a device affected their tinnitus before switching to the next one.
For most participants, the ringing decreased only when the device shocked and played sound — not just one or the other. Researchers found for most people, the ringing decreased slightly, but two participants reportedly lost their tinnitus after the treatment.
Although the findings are encouraging, it'll likely take a while before devices like these go public. The research team says it needs another clinical trial before developing a commercial version.
The Centers for Disease Control and Prevention says 100,000 Americans are living with sickle cell disease.
Pharmaceutical company Eli Lilly said people with qualifying insurance can get a three-month supply of the drug for as low as $25.
A recent study that found antibiotics used to treat sepsis and meningitis are less than 50% effective because they have become more resistant.
The CDC says millions of Americans could be affected by the long-lasting, difficult-to-treat disease.
The rules would go into full effect in 2025, and could serve as a blueprint for regulators elsewhere in the world.
"Godzilla Minus One" takes the franchise back to its deeply political roots of post-WWII Japan — and critics say it's now one of the best films.